Medicine shortages are worsening in Iran amid tightened US sanctions and a blockade, leaving many Iranians unable to access or afford life-saving drugs, according to Al Jazeera. Iranian authorities say the pharmaceutical sector will not collapse.
Key facts
- Medicine shortages are growing in Iran as US sanctions tighten, according to Al Jazeera.
- Al Jazeera reports many Iranians cannot access or afford life-saving drugs.
- Iranian authorities say the pharmaceutical sector will not collapse.
- Al Jazeera links the situation to a US blockade and tightened sanctions.
Medicine shortages are deepening across Iran as the United States tightens sanctions and enforces a blockade, according to Al Jazeera. The report says many Iranians are now unable to access or afford life-saving drugs.
Al Jazeera cites affordability and availability as central concerns for patients seeking medication.
Despite the reported difficulties, Iranian authorities have sought to reassure the public. According to Al Jazeera, officials say the country’s pharmaceutical sector will not collapse.
Al Jazeera links the reported shortages to tightened US sanctions and a blockade.
The full scale of the shortages, the specific drugs affected, and any US response are not detailed in the available reporting.
Why it matters
Access to affordable medicine is a basic health need, and shortages can threaten patients who rely on regular or specialised treatment. The report raises questions about the humanitarian impact of sanctions and blockades on civilian populations.
Frequently asked questions
Why are medicines becoming harder to get in Iran?
According to Al Jazeera, growing shortages are linked to tightened US sanctions and a blockade, leaving many Iranians unable to access or afford life-saving drugs.
Will Iran's pharmaceutical sector collapse?
Iranian authorities say it will not collapse, according to Al Jazeera, despite the current shortages.
Who is most affected by the shortages?
The Al Jazeera report indicates many ordinary Iranians cannot access or afford life-saving drugs, placing patients who depend on medication at particular risk.